Global Human Fibrinogen Market Growth 2025-2031

The global Human Fibrinogen market size is predicted to grow from US$ 1036 million in 2025 to US$ 2535 million in 2031; it is expected to grow at a CAGR of 16.1% from 2025 to 2031.

Fibrinogen (factor I) is a glycoprotein in vertebrates that helps in the formation of blood clots. Human Fibrinogen is used as a medicine for blood disease. Human Fibrinogen is a preparation of coagulation factors prepared from pooled plasma. Currently, only RiaSTAP (CSL Behring) is licensed in a number of countries for multiple indications including treating acute bleeding episodes with Hypofibrinogenemia. Other manufacturer’s products are justly used in local region or countries.

Global Human Fibrinogen key players include CSL Behring, LFB Group, Shanghai RAAS Blood Products, Jiangxi Boya Bio-Pharmaceutical, GREEN CROSS, etc. Global top five manufacturers hold a share about 90%. Asia-Pacific is the largest consumption market, with a share about 60%, followed by Americas and Europe, total have a share over 30 percent. In terms of product, Human Fibrinogen Concentrate is the largest segment, with a share over 99%. And in terms of application, the largest application is Surgical Procedures.

LP Information, Inc. (LPI) ' newest research report, the “Human Fibrinogen Industry Forecast” looks at past sales and reviews total world Human Fibrinogen sales in 2024, providing a comprehensive analysis by region and market sector of projected Human Fibrinogen sales for 2025 through 2031. With Human Fibrinogen sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Human Fibrinogen industry.

This Insight Report provides a comprehensive analysis of the global Human Fibrinogen landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Human Fibrinogen portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Human Fibrinogen market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Human Fibrinogen and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Human Fibrinogen.

This report presents a comprehensive overview, market shares, and growth opportunities of Human Fibrinogen market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Human Fibrinogen Concentrate
Animal Fibrinogen Concentrate

Segmentation by Application:
Congenital Fibrinogen Deficiency
Surgical Procedures

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
CSL Behring
LFB Group
Shanghai RAAS Blood Products
Jiangxi Boya Bio-Pharmaceutical
Hualan Biological Engineering
Harbin Pacific Biopharmaceutical
GREEN CROSS
Shanghai XinXing Medical
Octapharma

Key Questions Addressed in this Report

What is the 10-year outlook for the global Human Fibrinogen market?

What factors are driving Human Fibrinogen market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Human Fibrinogen market opportunities vary by end market size?

How does Human Fibrinogen break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.